Human Scleroderma Serum for Research

Our Scleroderma Serum is sourced from IRB-consented donors clinically diagnosed with scleroderma (systemic sclerosis). Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for detecting disease-specific autoantibodies and proteomic and biomarker studies.

Product Features

• Collected from clinically confirmed scleroderma donors
• IRB-approved protocols with documented consent

Donor Metadata

• Diagnosis confirmation
• Age, sex assigned at birth, and ethnicity
• Donor-reported allergy and infectious disease history

Applications

• Biomarker discovery for scleroderma
• Serum cytokine and protein profiling
• Therapeutic candidate screening and validation

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
• Documentation support available for regulatory review

Ordering and Customization

Scleroderma serum is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.